
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Astragalus membranaceus contains astragaloside IV and cycloastragenol that enhance immune function by activating T-helper cells and macrophages. This traditional Chinese medicine root also supports cardiovascular health through its polysaccharide compounds that reduce oxidative stress and inflammation.

Reported Benefits (Provisional)
Origin & History

Astragalus Membranaceus, known as Huang Qi, is a root native to China. It is harvested, sliced, and dried for use in traditional decoctions and modern supplements.
Research Narrative (Provisional)
Numerous studies, including RCTs, support astragalus's immune-boosting and anti-inflammatory effects. Human trials indicate potential benefits in kidney and cardiovascular health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains saponins, flavonoids, and polysaccharides. - Rich in antioxidants that support cellular health. - Provides essential amino acids and trace minerals.
Reported Mechanism (Provisional)
Astragaloside IV enhances immune function by upregulating T-helper cell proliferation and increasing interleukin-2 production. The polysaccharide compounds activate macrophages through Toll-like receptor pathways, while cycloastragenol protects telomeres and reduces cellular aging. These compounds also improve cardiovascular health by activating nitric oxide synthase and reducing inflammatory cytokines like TNF-alpha.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 2,400+ participants demonstrate astragalus extract (10-30g daily) increases immune cell activity by 20-30% within 8-12 weeks. Cardiovascular studies show 500-2000mg daily reduces systolic blood pressure by 10-15 mmHg and improves left ventricular function in heart failure patients. However, most studies are small-scale with 30-120 participants, and long-term safety data remains limited. Evidence quality is moderate, with some studies lacking proper placebo controls.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







